Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biogen Inc (NASDAQ:BIIB)

335.68
Delayed Data
As of Oct 16
 -1.96 / -0.58%
Today’s Change
244.28
Today|||52-Week Range
344.37
+28.51%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Operating ActivitiesNet Income / Starting Line1.9B2.9B3.6B3.7B
 
 
 
 
 
Depreciation531.7M637.3M600.4M682.7M
 
 
 
 
 
Total Other Cash Flow108.7M155.9M243.6M246.0M
 
 
 
 
 
Funds From Operations2.3B3.4B4.3B4.4B
 
 
 
 
 
Funds From/For Other Operating Expenses-87.4M484.4M575.5M-73.0M
 
 
 
 
 
Net Cash Flow - Operating Activities2.3B2.9B3.7B4.5B
 
 
 
 
 
 
InvestingIncrease In Investments-3.3B-3.6B-6.9B-7.9B
 
 
 
 
 
Decrease In Investments5.2B2.7B4.1B7.4B
 
 
 
 
 
Capital Expenditures-246.3M-287.8M-643.0M-616.1M
 
 
 
 
 
Net Assets From Acquisitions -15.0M0.00-198.8M0.00
 
 
 
Other Investing - Uses---391.0M-909.9M-1.2B
 
 
 
 
Other Investing - Sources7.4M------
 
 
Net Cash Flow Investing-1.6B-1.5B-4.6B-2.5B
 
 
 
 
 
 
FinancingShort Term Borrowings----------
Long Term Borrowings0.000.005.9B0.00
 
 
Long Term Debt Reduction-452.3M-2.7M-2.1M-2.7M
 
 
 
 
 
Net Proceeds Stock Sale66.8M54.9M54.2M43.7M
 
 
 
 
 
Common Preferred Redeemed-400.3M-886.8M-5.0B-1.0B
 
 
 
 
 
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing73.5M96.4M78.2M12.6M
 
 
 
 
 
Other Uses - Financing4.1M17.7M74.4M41.4M
 
 
 
 
 
Net Cash Flow - Financing-716.5M-755.9M986.4M-987.8M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash8.0M-40.9M-45.8M-31.3M
 
 
 
 
 
 
Net Change In Cash23.9M643.3M148.9M1.0B